Misoone (Misoprostol)

Misoprostol, the active ingredient in Misoone, is a prostaglandin E1 analog presented as an oral tablet for systemic use. It is employed to protect the gastric mucosa in patients receiving NSAIDs and to induce uterine contractions for obstetric indications, under medical supervision and in controlled clinical settings.

GNH USA supplies Misoone as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance. Our distribution network reaches Europe, Asia, Africa and the Americas, ensuring timely delivery to accredited health‑care institutions.

Misoprostol acts on prostaglandin receptors to modulate gastric acid secretion and uterine smooth‑muscle activity. - NSAID‑induced gastric ulcer prevention: reduces gastric acid secretion and enhances mucus protection, lowering ulcer risk in patients taking NSAIDs. - Labor induction: stimulates coordinated uterine contractions to initiate or augment labor under obstetric supervision. - Medical termination of pregnancy: induces uterine activity to expel early gestational tissue. - Management of incomplete abortion: promotes evacuation of retained products after a partial miscarriage.

Misoprostol may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Diarrhea: frequent loose stools. - Abdominal cramping: painful uterine‑like cramps. - Nausea: feeling of sickness. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Severe uterine hyperstimulation: excessive contractions that may compromise fetal oxygenation. - Hemorrhage: significant vaginal bleeding. - Allergic reaction: rash, itching, swelling, or anaphylaxis.

When prescribing Misoprostol, clinicians should observe several safety considerations. - Assess renal function: dose adjustment may be needed in severe renal impairment. - Evaluate cardiovascular status: prostaglandins can affect blood pressure and cause vasodilation. - Review concomitant NSAID use: combined therapy may increase gastrointestinal risk. - Avoid use in patients with known hypersensitivity to prostaglandin analogues. - Monitor fetal status: when used in pregnancy, fetal heart rate monitoring is recommended. - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and light.

Misoprostol can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Combined use with high‑dose NSAIDs: may blunt gastroprotective effect. - Antacids containing magnesium or aluminum: can reduce absorption. - Oxytocin: additive uterine stimulation may cause hyperstimulation.

Moderate Interactions (Monitor Closely): - Anticoagulants: increased risk of bleeding with uterine hemorrhage. - Antihypertensives: prostaglandin‑mediated vasodilation may enhance blood‑pressure‑lowering effect. - Rifampin: enzyme induction may lower Misoprostol plasma levels.